Immune response to vaccination with AVA in cynomolgus macaques (NHP preexposure prophylaxis study). Immune response to vaccination with AVA in cynomolgus.

Slides:



Advertisements
Similar presentations
Optimizing the Use of Anthrax Vaccine Workshop on the Biology of Anthrax, Cardiff, Wales 12 March, 2014 Thomas Waytes, MD, PhD V.P. Medical Affairs.
Advertisements

Human and Rhesus Macaque Immunologic Responses To Anthrax Vaccine Adsorbed CDC Anthrax Vaccine Research Program Conrad P. Quinn Chief, MPIR Laboratory.
Pathway to Licensure for Protective Antigen-based Anthrax Vaccines for a Post-exposure Prophylaxis Indication Using the Animal Rule.
ALT-803 administration increases peripheral blood cell counts of lymphocyte subsets in cynomolgus monkeys. ALT-803 administration increases peripheral.
FMDV-specific IgG, IgG1, and IgG2 in sera of guinea pigs (n = 6/group) immunized on days 1 and 21 by intramuscular injection of FMDV antigens (type O)
Virus-specific serum antibody response of BALB/c mice to DNA prime followed by VRP boost. Virus-specific serum antibody response of BALB/c mice to DNA.
Protection from influenza virus challenge.
FMD VP1-specific IgG, IgG1, and IgG2 in sera of guinea pigs (n = 6/group) immunized on days 1 and 21 by intramuscular injection of FMDV antigens (type.
Detection of CSFV-specific antibodies in immunized/challenged pigs using blocking ELISA. Groups of pigs (n = 5) were inoculated with different doses of.
Virus-specific serum antibody response of BALB/c mice to DNA prime followed by VRP boost. Virus-specific serum antibody response of BALB/c mice to DNA.
IL-18; IL-18BP; and free, biologically active IL-18 levels in nonsevere versus severe dengue cases. IL-18; IL-18BP; and free, biologically active IL-18.
DCs induce the proliferation of autologous T cells.
Immune response to vaccination with AVA in healthy human subjects (human immunogenicity study). Immune response to vaccination with AVA in healthy human.
Survival of BALB/c mice after HK/Syd challenge.
Relationship between prechallenge AVA-induced TNA levels and probability of animal survival following lethal challenge with B. anthracis spores in rabbit.
Serum neutralizing antibody response of BALB/c mice to DNA prime followed by VRP boost. Serum neutralizing antibody response of BALB/c mice to DNA prime.
Survival and time to death of NZW rabbits following vaccination with AVA and subsequent lethal B. anthracis spore challenge (rabbit preexposure prophylaxis.
Tetramer staining performed to determine frequencies of epitope-specific T cells after clearance of HPV16 infection but prior to isolation of T-cell clones.
Comparison of relative activity of Adjuplex and other commonly used adjuvants. Comparison of relative activity of Adjuplex and other commonly used adjuvants.
Survival of NZW rabbits following lethal B
Immune response to vaccination with AVA in NZW rabbits (rabbit preexposure prophylaxis study). Immune response to vaccination with AVA in NZW rabbits (rabbit.
Antibody endpoint titers induced by PfCelTOS vaccines containing various adjuvant formulations with emulsion doses of 0.5% to 2% (vol/vol) oil, as measured.
Survival and time to death of cynomolgus macaques following vaccination with AVA and subsequent lethal B. anthracis spore challenge (NHP preexposure prophylaxis.
Longevity of mucosal and systemic antibody responses induced by pulmonary vaccination. Longevity of mucosal and systemic antibody responses induced by.
Increased proinflammatory cytokine production is dependent on both the training interval and the resting time. Increased proinflammatory cytokine production.
Contribution of individual serovars within serogroups isolated in the United States in Contribution of individual serovars within serogroups isolated.
Pulmonary vaccination induces a long-term immune memory response to antigen challenge. Pulmonary vaccination induces a long-term immune memory response.
Anti-inflammatory cytokine production is increased in trained monocytes. Anti-inflammatory cytokine production is increased in trained monocytes. (A) IL-10.
ROS production is a component of trained immunity for some stimuli.
Reproducibility of LPA results for cryopreserved PBMC after variable periods of storage in liquid nitrogen. Reproducibility of LPA results for cryopreserved.
Viability and viable cell recovery of cryopreserved PBMC after variable periods of storage in liquid nitrogen. Viability and viable cell recovery of cryopreserved.
Prime and boosts with PBK001 vaccine provided 100% protection with low bacterial burden in organs. Prime and boosts with PBK001 vaccine provided 100% protection.
Antibody endpoint titers induced by PfCelTOS vaccines containing various adjuvant formulations with emulsion doses of 0.02% to 2% (vol/vol) oil, as measured.
Trained immunity induction of glycolysis.
Intranasal immunization of mice with S
Cross-protection against variants within a subtype after intranasal immunization with vaccine from MDCK cell-adapted Vac-3 P22. Cross-protection against.
Antibody titers against surface antigens of B
Trained immunity effects on cell morphology and numbers.
FeLV p27 antigenemia ELISA data.
RTA pepscan analysis of sera from RiVax- and RVEc-immunized mice.
Scattergrams showing IgG- and IgA-specific OD490 values measured with the Campylobacter-specific P18/P39 ELISA in sera from healthy controls and from GBS.
RTA-specific serum IgG antibody titers and TNA in mice immunized with RiVax or RVEc. RTA-specific serum IgG titers after the second (A) or third (B) immunizations.
NK activity in healthy donors (n=51) and patients with FRH upon recurrence (n=28) and remission (n=23). NK activity in healthy donors (n=51) and patients.
Dilution of anti-C6 monoclonal antibody shows the broader linear range of the Multiplex assay in comparison to standard ELISA. Shown is the dilution of.
Reproducibility of CD4+ and CD8+ T-cell enumeration with cryopreserved PBMC after variable periods of storage in liquid nitrogen. Reproducibility of CD4+
Reproducibility of the enumeration of the percentages of CD4+ CD45RA+ CD95−, CD4+ CD38+, and CD8+ CD38+ in cryopreserved PBMC after variable periods of.
Antibody titers against surface antigens of M
Effect of nivolumab or ipilimumab on immune responses to vaccination in cynomolgus monkeys. Effect of nivolumab or ipilimumab on immune responses to vaccination.
Relation between the total white blood count and the absolute lymphocyte count prior to the first vaccination and the response to vaccination. Relation.
B- and T-cell activity induced by immunization.
DTH responses to multiple components of the ID93 fusion protein.
Individual values for the tTg-IgA Celikey assay (A), the tTG-IgG Celikey assay (B), the DGP (IgA+IgG) screen (C), and the tTG-IgA Immulite 2000 assay (D),
TNA associated with FD3-specific Abs.
Group-averaged IL-10 levels (in pg/ml) from the Luminex assay for control, CFS with FM, and CFS without FM groups. Group-averaged IL-10 levels (in pg/ml)
Diethylamine-based measles avidity assay.
Long-lived antibody-secreting cells in the bone marrow, induced by PfCelTOS vaccines containing various adjuvant formulations with emulsion doses of 0.02%
Long-lived antibody-secreting cells in the bone marrow, induced by PfCelTOS vaccines containing various adjuvant formulations with emulsion doses of 0.5%
Fig. 1 ZMAb improves survival of EBOV-challenged NHPs
Time to culling for mastitis among J5 vaccinates and controls
Antigen-specific cytokine production detected by multiplex bead assay (Luminex) 3 weeks after the 3rd immunization. Antigen-specific cytokine production.
Antigen-specific cytokine-producing cells (IFN-γ and IL-5) detected by ELISPOT assay 3 weeks after the 3rd immunization. Antigen-specific cytokine-producing.
Anti-PT IgG results from 227 patients with coughs of unknown etiology who reported the severity of cough on a scale from 0 to 10. Anti-PT IgG results from.
Comparison of quantitative results obtained with the Enzygnost antiVZV/IgG, Serion ELISA Classic VZV IgG, and Euroimmun anti-VZV ELISA (IgG) tests for.
Lkt antibody titers of vaccinated and control groups of BHS
Determination of CD-206 and TLR-2 receptors in immune cells in lamina propria of the small intestine of mice given L. casei. Determination of CD-206 and.
Schematic presentation of the major domains of Alps, the signal peptide (S), the N-terminal region (N), the repeat region (R), and the C-terminal region.
Time to culling for all reasons among J5 vaccinates and controls
IgA and IgG antibodies reactive to TT, alpha-toxin, and BSA in two groups of chickens 2 weeks after oral gavage with probiotics or with PBS. The two groups.
Distribution of responses to vaccine antigens in the culture-positive individual group and the control group. Distribution of responses to vaccine antigens.
Variability between laboratories in titer estimations (expressed as GCV on the y axis) tends to be higher for samples in low measurement ranges and to.
Presentation transcript:

Immune response to vaccination with AVA in cynomolgus macaques (NHP preexposure prophylaxis study). Immune response to vaccination with AVA in cynomolgus macaques (NHP preexposure prophylaxis study). Animals were immunized with serial dilutions of AVA on days 0 and 28. Control animals were immunized with PBS. On day 70, all monkeys were challenged via inhalation with 200 LD50 of aerosolized B. anthracis spores. Each TNA NF50 value was calculated as the ratio of the ED50 of the test sample to the ED50 of the reference standard. Individual values below the LOQ were replaced with the LOQ value (0.105) for statistical analysis purposes. Postchallenge TNA NF50 GMTs (days and 133) were calculated using group sizes based on surviving animals: 8 (group 1), 7 (group 2), 4 (group 3), 3 (group 4), 1 (group 5). Pre- and postchallenge TNA responses are separated by a vertical dashed line. Boris Ionin et al. Clin. Vaccine Immunol. 2013; doi:10.1128/CVI.00099-13